Medicine and Dentistry
Pulmonary Hypertension
100%
Dyspnea
32%
Disease
31%
Exercise
29%
Idiopathic Pulmonary Fibrosis
28%
Enteric Feeding
26%
Stress Ulcer
26%
Stroke Volume
26%
Pulmonary Artery
23%
Intensive Care Unit
21%
Hemodynamic
21%
Vasodilator Agent
21%
Gasping
20%
Echocardiography
19%
Case Presentation
17%
Gastrointestinal Bleeding
17%
Treprostinil
16%
Atrial Septal Defect
16%
Obstructive Sleep Apnea
16%
Mental Health
14%
Interstitial Lung Disease
14%
Epileptic Seizure
13%
Central Sleep Apnea
13%
Intractable Epilepsy
13%
Ischemic Mitral Valve Regurgitation
13%
Post-Hoc Analysis
13%
Human Immunodeficiency Virus
13%
Asthma
13%
Clinician
13%
Drug Resistant Epilepsy
13%
Heart Amyloidosis
13%
Quality Improvement
13%
G Protein Coupled Receptor
13%
Cohort Analysis
13%
Virus Infection
13%
Bleeding
13%
Therapy Delay
13%
Bronchodilating Agent
13%
Rosai-Dorfman Disease
13%
Infectious Complication
13%
Chronic Obstructive Pulmonary Disease
13%
Adenoid Hypertrophy
13%
Tertiary Care
13%
Ankle Brachial Index
13%
Cervical Spine Radiography
13%
Anomalous Pulmonary Venous Connection
13%
Mediastinitis
13%
Ammonium
13%
Sleepwalking
13%
Upper Gastrointestinal Bleeding
13%
Keyphrases
Environmental Metals
26%
Inhaled Treprostinil
22%
Pulmonary Hypertension
20%
Bridge-to-surgery
13%
Fibroblasts
13%
Acute Ischemic Mitral Regurgitation
13%
Enteral nutrition
13%
Bleeding
13%
Event Distribution
13%
Upper Gastrointestinal Tract
13%
Pseudoaneurysm
13%
Interstitial Lung Disease
13%
Closed Model
13%
Treatment Delay
13%
Pulmonary Hypertension Treatment
13%
Oropharyngeal
13%
Fibrosing Mediastinitis
13%
Defect Management
13%
Necrobiotic
13%
Adenoid Hypertrophy
13%
Tyvaso
13%
Inhalable Dry Powder
13%
Extraintestinal Manifestations
13%
Cryptococcus
13%
Fibroblast Heterogeneity
13%
Typical Carcinoid
13%
Case-cohort Study
13%
International Case
13%
Redox Homeostasis
13%
Molar Tooth Sign
13%
Vici Syndrome
13%
Real-world Treatment Patterns
13%
G Protein-coupled Receptor
13%
Vasodilator
13%
Antimony
13%
Associated Diseases
13%
Peritonitis
13%
Massive Pulmonary Embolism
13%
Hoarseness of Voice
13%
Cardiovascular Effects
13%
Resident Continuity Clinic
13%
Proton Pump Inhibitors
13%
MR-proADM
13%
Smoking-related Interstitial Fibrosis
13%
Krukenberg Tumor
13%
Carotid Flow Time
13%
Pulmonary Artery
13%
Fraction Volume
13%
Wood
11%
Cardiovascular Disease
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
86%
Treprostinil
40%
Stress Ulcer
26%
Disease
26%
Sleep Disordered Breathing
26%
Clinical Study
24%
Gastrointestinal Hemorrhage
22%
Apnea
22%
Interstitial Lung Disease
14%
Tolerability
13%
Lung Embolism
13%
Mediastinitis
13%
HIV
13%
Inflammation
13%
Cardiovascular Disease
13%
Hypertension
13%
Peripheral Occlusive Artery Disease
13%
G Protein Coupled Receptor
13%
Heart Atrium Septum Defect
13%
Proton Pump Inhibitor
13%
Proadrenomedullin
13%
Down Syndrome
13%
Heart Failure
13%
Case-Control Study
13%
Placebo
12%
Clinical Trial
12%
Heavy Metal
10%
Prevalence
10%
Human Immunodeficiency Virus Infection
10%
Atherosclerosis
10%
Disease Exacerbation
9%
Retrospective Study
9%
Lung Disease
8%
Combination Therapy
7%
Ion Channel
6%
Obstruction
6%
Pantoprazole
6%
Coronary Artery Disease
6%
Heart Ventricle Remodeling
6%
Pathophysiology
6%
Syndrome
6%
Thorax Pain
6%
Heart Infarction
6%
Rectum Carcinoma
6%
Vascular Remodeling
6%
Epileptic Absence
6%
Brain Natriuretic Peptide
5%
Hypopigmentation
5%
Hormone Precursor
5%